The document analyzes the healthcare industry in the U.S. and ways IT can help small businesses insure employees. It discusses four key factors impacting the industry: the Affordable Care Act, digital/IT infrastructure, advances in omics sciences, and the rising global middle class. The recommendations suggest that IT companies can create customized solutions to help small businesses comply with the ACA's insurance mandate for employees.
Seminar 9 health care delivery system in united states of americaDr. Ankit Mohapatra
Health care organization
Health financing in US
Payment mechanism
Health expenditure
Human and physical recourses
Public health
Patient pathway into health care
Provision of services
ACA
US vs India Healthcare
Seminar 9 health care delivery system in united states of americaDr. Ankit Mohapatra
Health care organization
Health financing in US
Payment mechanism
Health expenditure
Human and physical recourses
Public health
Patient pathway into health care
Provision of services
ACA
US vs India Healthcare
Integrity driven performance in the pharmaceutical industryOnly Medics
The foundation of any sustainable and profitable business model requires the trust of consumers, regulators, investors, and creditors. Relative to their counterparts in other sectors, however, pharmaceutical companies find themselves party to a more involved and demanding social contract. The public expects pharmaceutical companies to address social needs as well as earn a financial return.
Markets and Healthcare Services in Malaysia: Critical IssuesEyesWideOpen2008
An October 2011 academic paper by University of Malaya and Universiti Tun Abdul Razak. It calls for improvement of present system and increased federal funding. But it is ignored by the government in favour of 1Care's model.
Excerpt:
The arguments obviously call for Government funding of healthcare in Malaysia to be raised to around 10 per cent of overall government expenditure so that public hospitals will enjoy enough resources to provide service comparable to developed countries.
These resources should be targeted at raising remuneration of personnel, more medical equipment, greater access to pharmaceutical drugs and materials, as well as quality building support. In addition, the government should introduce and implement merit-based promotion personnel policies in public hospitals.
From Epstein Becker Green and EBG Advisors: Policy & Legal Trends Impacting Health Care Investment - for more information, please visit http://www.ebglaw.com/PEdownloads
Transforming Healthcare: The Promise of InnovationHealth Catalyst
A number of powerful technologies are on the verge of producing dramatic change in how, when and where care is delivered, including artificial intelligence, genomics, monitoring sensors, robotics, nanotechnology, 3D printing, mobile computing technologies and others. This technology-driven change will dramatically impact all healthcare providers, and it will propel healthcare into the realm of Big Data.
Participants will:
Appreciate the role of innovation in healthcare's future.
Understand the classes of technology that will foster innovation and drive change.
Learn how technology-driven change will support data-driven improvement and population health management.
Know how these technologies will impact analytics.
Understand the application of transformational principles in light of the many engaging practitioner discussions at the recently concluded Health Analytics Summit.
The future is becoming clearer and it promises to be exciting, impactful, and powerful for patients and healthcare providers alike.
Miron Healthcare Services, along with a fresh wave of cutting-edge healthcare facilities, is reinventing the concept of typical healthcare and reviving the spirit of the ideal patient experience.
White Paper - Internet Marketing Strategies For The Medical Device Industryjerryme5
This is a White Paper that I wrote, while employed at Exemplum, that talks about various marketing strategies that medical device companies can use to leverage the Internet to market their products more effectivelty.
Here we discuss the sectoral winners and losers for Patient Protection and Affordable Healthcare Act I (Obamacare) along with the key factors driving these trends due to Obamacare. Check out the Special Report on Obamacare from Aranca!
Here we discuss the sectoral winners and losers for Patient Protection and Affordable Healthcare Act I (Obamacare) along with the key factors driving these trends due to Obamacare. Check out the Special Report on Obamacare from Aranca's Business Research Experts!
The rapid increase in population, rising burden of noncommunicable chronic diseases such as diabetes and obesity , care costs skyrocketing, and the global shortage of doctors, nurses, and technicians are leading to an increasing demand for resources to support healthcare. These global challenges will seriously affect the healthcare delivery is the US and around the world. The current technological advancements are leading to the emergence of the so called Health 4.0 revolution. Healthcare 4.0 has the potential to enable new healthcare related processes such as home care and personalized treatments and transform them into services. This paper provides an introduction to the emerging area of Healthcare 4.0 and identify its opportunities, benefits, and challenges. Matthew N. O. Sadiku | Adedamola A. Omotoso | Sarhan M. Musa ""Healthcare 4.0: An Introduction"" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-4 | Issue-2 , February 2020, URL: https://www.ijtsrd.com/papers/ijtsrd29791.pdf
Paper Url : https://www.ijtsrd.com/engineering/other/29791/healthcare-40-an-introduction/matthew-n-o-sadiku
The post-COVID Value Shift & How MedTech Companies can CapitalizeGreenlight Guru
The ongoing COVID-19 pandemic has fundamentally shifted the perception of value globally. The healthcare industry, and MedTech (Devices, Diagnostics and Digital Health) stand to benefit enormously. While the world waits for a vaccine, it has been MedTech companies and their solutions that have protected healthcare workers, kept patients alive, and been the focus of government policy and investment. The policy and funding shifts have been aligned to value-based healthcare principals, of which MedTech was already a leader. Discover how you can align your organization, and engage with key stakeholders to capitalize on this massive shift in value perception.
Takeaways:
- How the fundamental structure of healthcare is set to change
-How this fundamental change will benefit MedTech companies
-What you need to do in order to make this change sustainable within your organization
This session took place live at the Greenlight Guru True Quality Virtual Summit, a three-day event for medical device professionals to learn to get their devices to market faster, stay ahead of regulatory changes, and use quality as their multiplier to grow their device business.
Medical Automation Technologies, Products and MarketsReportLinker.com
REPORT SCOPEINTRODUCTIONSTUDY BACKGROUNDSince the enactment of the Patient Protection and Affordable Care Act (PPACA) in 2010, the U.S. government and healthcare industry have stepped up their efforts to increase the efficiency of health care, with the twin objectives of containing costs and improving the quality of care. Information technology is at the forefront of this effort; indeed, BCC Research recently completed a study of healthcare IT technologies, products, and market opportunities (Report HLC048C).However, healthcare IT is just one segment of the broader field of medical automation, a field that many experts believe will revolutionize the way medical care is provided. Automated delivery of health care can contain costs, reduce errors, and improve outcomes.Major improvements in production efficiency and product quality have been demonstrated through automation in factories. Medical automation will borrow many of the principles developed in factory automation and apply them to the medical environment. Automation will have to demonstrate, however, that it is safe for patients, that it has more flexibility to accommodate the complex tasks within the hospital, and that it can generate a reasonable return on investment.GOALS AND OBJECTIVESThe report is an update of an earlier report published by BCC in 2009, and its goal is to identify and quantify the current and future market opportunities associated with medical automation. In support of this goal, here is a list of its specific objectives: * Identifying the medical automation technologies with the greatest commercial potential over the next 5 years (2011 to 2016). * Estimating the market for these technologies in 2010. * Analyzing the technical, economic, and other demand drivers for these products, and other prerequisites of success in these markets. * Projecting the potential U.S. markets for these technologies through 2016.INTENDED AUDIENCEThe report is intended especially for healthcare automation suppliers, as well as government agencies, healthcare policy analysts, and others seeking to understand the costs and preconditions for success of healthcare automation initiatives. Although the report is structured around specific technologies, it is largely nontechnical in nature. That is, it is concerned less with theory and jargon than with what works, how much of what works the market is likely to purchase, and at what price. As such, the report's main audience is composed of executive managers and marketing and financial analysts. It is not written specifically for scientists and technologists, although its findings are concerned with the markets for their work, including the availability of government and corporate research funding for different technologies, and applications that should interest them as well.SCOPE AND FORMATAs indicated above, medical automation is closely related to healthcare IT, which is the subject of a companion BCC report, HLC048C Healthcare Information Technology. However, for the purposes of this report, medical automation technologies are defined as technologies for the electromechanical control or operation of diagnostic or therapeutic processes or systems or training of healthcare professionals, which result in a reduced need or eliminate the need for human intervention. Examples of such medical automation technologies are listed: * Automated health assessment and monitoring technologies * Automated medical imaging and image analysis * Automated prescription fulfillment devices * Automated therapeutic (nonsurgical) devices * Robotic and computer-assisted surgical equipment * Automated laboratory testing and analysis * Automated healthcare logistics, resource, and patient tracking * Automated medical trainingThe study format includes the following major elements: * Executive summary * Definitions * Medical automation technologies and applications * Enabling technologies * End
For the complete report, get in touch with us at : info@netscribes.com
Abstract:
Netscribes’ latest market research report titled Medical Devices Market in India 2014 captures the technologically driven aspect currently prevailing within the Indian healthcare sector. The booming Indian economy is also witnessing a tremendous surge in the domestic healthcare scenario which, in turn, is leading to perpetual demand for high quality medical products. The demand for high-end, quality devices is especially driven by the private healthcare sector in its efforts to provide sophisticated treatment to patients. However, India lags behind in manufacture of technologically advanced high-end medical equipment, and instead has to rely upon imports from multinationals with extensive service networks. On the other hand, the market for less cost intensive medical supplies and disposable equipment is dominated by domestic manufacturers.
Due to the industry’s dependence on imports, multinationals are showing interest in relocation of manufacturing facilities to India as well as in forging alliances with healthcare sector stakeholders in order to capture greater market share. This brings into focus a key role played by the government that involves taxation and import regulations. The government also takes up several initiatives for the benefit of the market.
Coverage
• Overview of the medical devices market in India and forecasted market size data over 2012 to 2018
• Market Segmentation of medical devices by types
• Overview of the medical devices market in India by types and forecasted market size data over 2012 to 2018
• Snapshot of market segmentation of medical equipment
New and Refurbished Medical Equipment
Regional Demand for Medical Equipment
• Export-import overview of medical devices, value of export-import over 2009-10 to 2012-13 and country-wise value of export-import for 2011-12 and 2012-13
• Qualitative analysis of market drivers, challenges, trends and regulatory measures taken by the government
• Overview of the government bodies and their responsibilities
• Analysis of the competitive landscape and detailed profiles of major players
Why Buy
• Get a clear understanding of the medical devices market in India, how it operates and the various stages of the value chain
• Understand the current market segmentation and future growth potential of the medical devices market in India till 2018 and plan strategies to gain from it
• Strategize marketing, market-entry, market expansion, and other business plans by understanding factors influencing growth in the market
• Understand your competitors’ business structures, strategies and prospects, and respond accordingly
• Make more informed business decisions with the help of insightful recommendations provided to succeed in the Indian medical devices market
Managing the Pharmaceutical Supply Chain: ‘By Wire’ “The next big thing”IJAEMSJORNAL
The emergence of computers in the 20th century has enabled the evolution of new age technology. Today, advances in information technology, the globalization of markets, and the push toward efficiency and sustainability continue to create challenges and opportunities that did not exist few years ago. In recent years, the ever-increasing technical complexity of standard consumer goods, combined with the ever-increasing size and depth of the global market, indicate that the connection between vendors and consumers is usually the link in the supply chain. The stampede to acquire new technologies, scientific innovations and managing technology are an imperative in every sectorfor which the health care industry is not an exception. In the healthcare industry, there could be added risk and complexity in the supply chain that can have adverse effect on patient safety and health outcomes. Hospitals and health systems are beginning to tap into the ignored opportunity: “pharmaceutical supply chain optimization”. Businesses such as healthcare will have to reorganize and continue to modify their business-model to capture potential benefits on emerging technological innovation that can positively affect patient care and costs.
Business Plan for Indian Health Care IndustryVenkatesh Kg
Business Plan in using SAAS in Health Care sector to improve customer retention & enhance new customer acquisition for multi-speciality hospitals in India.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
3. PROBLEM STATEMENT:
To analyse the healthcare industry in U.S.A. and ways to improve it.
How IT can be used to better serve the SME in enabling their employees to get insured?
BACKGROUND INFORMATION:
The analysis is done taking into consideration four major factors affecting the industry currently
1)Patient Protection and Affordable Care Act(2010)
2)Digital & IT & Infrastructure
3)Rapid Advances in Omics Sciences
4)Rise of global middle class
Of particular interest to us is the digital revolution as it creates enormous opportunities.
Since the industry is in a state of flux opportunities exist to create and capture value.
RECOMMENDATIONS:
Obamacare mandates compulsory insurance for all. This forces the small employers to provide insurance for their
employees. The IT companies can target and customize their solutions to create unique solutions for SME.
4. The GDP of USA is $16.8 trillion
Population: 316.8 million
There are 50 states and 14 union territories having
their own laws
Besides the state laws there are federal rules as well
There are only two political parties Republican and
Democrats
The Democrats are currently the ruling party
INDUSTRY
PLAYERS
INVOLVED
CHALLANGES ANALYSIS SUGGESTIONS
COUNTRY – U.S.A.
HOFSTEDE
DIMENSIONS
POWER DISTANCE
INDIVIDUALISM vs
COLLECTIVISM
MASCULINITY vs
FEMINITY
UNCERTAINITY
AVOIDANCE
LONG vs SHORT TERM
ORIENTATION
INDULGANCE vs
RESTRAINT
U.S.A. 40 91 62 46 26 68
MAP OF U.S.A.
5. The global spending on healthcare industry is $6.45
trillion
The U.S. accounts for $2.86 trillion
The United States spent 17.2% of its GDP on
healthcare which is more than any other country in the
world
By 2020, U.S. will spend $4.6 trillion on health care –
approximately 20 percent of U.S. GDP
The U.S. spends $8,608 per capita on healthcare which
is the highest in the world
This high spending has not converted into improved
health of the population
The U.S. ranks 38th when compared with other
developed nations in terms of health outcomes
The healthcare industry is in a state of change due to
the approval of the Obamacare Act.
Lack of insurance causes nearly 48,000 deaths
HEALTHCARE INDUSTRY
INTRODUCTION
PLAYERS
INVOLVED
CHALLANGES ANALYSIS SUGGESTIONS
6. PORTER 5 FORCES
-Hospitals
BARRIERS TO ENTRY
More capital intensive (high cost
of medical equipment & surgical
devices.).
INDUSTRY COMPETITION
Post PPACA, because of
protocolization, there is high
competition not only in small/large
scale hospitals but across all
hospitals in this industry.
POWER OF SUPPLIERS
AMA restriction on adding doctors
to the system is fixed (100,000)
making doctors & medical schools
more powerful.
POWER OF BUYERS
Lesser involvement of patients
because of lesser transparency in
hospital charges - insurance
agencies act as intermediaries.
THREAT OF SUBSTITUTES
Medical tourism -treatments
offered at lower charges in other
nations (Indonesia, Thailand & India
to mention a few.)
INTRODUCTION
PLAYERS
INVOLVED
CHALLANGES ANALYSIS SUGGESTIONS
8. High expenditure of healthcare is not followed by
increase in health of population
Cost of healthcare is shooting up
The number of doctors being added to the system is
fixed at 100,000 by American Medical Association
(AMA) leading to a shortage of doctors for primary
care
The average wage of doctors is double that of the
doctors in Europe
Cost of administration is 33% of the total expenditure
which is nearly double that in other countries
A major problem is the fact that insurance companies
are used to settle the bills and patients do not actually
know the cost of healthcare
The uninsured patients often do not get adequate care
Due to this emergency wards in the hospitals are used
by uninsured patients for treatment creating a drag on
the system
True emergency cases are difficult to treat because of
crowding in the system by uninsured patients
25% of senior citizens filed for bankruptcy due to
medical bills
The younger population is becoming unhealthy
especially the issue of chronic obesity
CHALLENGES
INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
ANALYSIS SUGGESTIONS
9. KEY DRIVERS OF HEALTHCARE INDUSTRY
INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
CHALLANGES SUGGESTIONS
1.PATIENT PROTECTION AND AFFORTABLE CARE ACT (2010) – OBAMACARE – PPACA
– ACA
2.DIGITAL AND INFORMATION TECHNOLOGY AND INFRASTRUCTURE
3.RAPID ADVANCES IN THE OMICS SCIENCES
4.RISE OF THE GLOBAL MIDDLE CLASS
The healthcare industry in U.S.A. is primarily affected by four major factors recently
10. Increase quality and affordability of health insurance
Lower uninsured rate by expanding public and private
insurance coverage
Reducing cost of healthcare for governments and
industries
GOALS - PPACA
• Prohibits insurers from denying insurance coverage due to
pre-existing medical conditions excluding tobacco usage
• Medicaid eligibility expanded. Several states have opted
out of this
• Pays for preventive, curative and palliative care
• Comparison of insurance plan prices across different states
• Minimum standards for health insurance are established
• Independent payment advisory board to recommend
changes to Medicaid system
• Community health organizations provide healthcare locally
FEATURES
MANDATE: Employer mandate and Individual mandate. Employers with more than 50 employees are required to insure their
employees or pay additional tax. Each individual is also required by law to get insured or pay penalty.
SUBSIDIES: Individuals who are below 400% of federal poverty level have various subsidies by which the government transfers
a large portion of the premium back to their bank account.
INSURANCE EXCHANGES: Websites will be used for this (healthcare.gov). Companies can list only approved plans here. The
offerings must contain options for the economically weker segments.
INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
CHALLANGES SUGGESTIONS
IMPLEMENTATION: The plan is getting implemented in phases and final implementation happens only in 2020.
LEGAL AND LEGISLATURE: The courts have ruled that each state has to decide on implementing the plan. Republicans have
opposed the PPACA and are actively trying to repeal the law.
1.OBAMACARE
11. PATIENT PROTECTION AND AFFORTABLE CARE ACT (2010) – EXPECTED IMPACT
INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
CHALLANGES SUGGESTIONS
The expected impact of PPACA on the healthcare industry are as follows:
1)AFFORDABLE CARE ORGANIZATIONS (ACO): Group of agencies working together to reduce costs (Section 3022, PPACA)
2)INDUSTRY TRANSPARENCY: Increase in information sharing among all the involved parties
3)INDUSTRY COLLABORATION: PPACA encourages the various players to collaborate and provide value to the patients
4)PROTOCOLIZATION: Industry best practices become protocols for treatment. Patients have more control over
healthcare
5)BUNDLED PAYMENTS: Drives the industry to explicitly link cost to value and then to quality outcomes. Reduce costs
6)TIERED DELIVERY MODELS: A range of plans will emerge to cover the whole population irrespective of income
7)HEALTH ECOSYSTEMS: Linking together of companies will change the way industry operates
8)HEALTH PLATFORMS: Various IT solutions will emerge to provide support to the companies and individuals
9)DIGITAL & IT INVESTMENTS: Increase in investments in the digital domain and software purchases
12. Digital revolution has changed the way the all industries
operate
It has transformed the healthcare industry in three
fundamental ways health consumer level, enterprise level
and industry level.
DIGITAL REVOLUTION 1)HEALTH CONSUMER LEVEL: Three major factors have
changed the way industry operates.
a)Social networking: The rise of health social networks like
Patients Like Me make the customers aware
b)Mobile: Devices and wearable technology which enable
providing consistent customer experience. MedAdherence
c)Analytics: Data about the patient can be collected
continuously through monitoring systems
INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
CHALLANGES SUGGESTIONS
2.DIGITAL AND IT AND INFRASTRUCTURE
2)ENTERPRISE LEVEL:
• Care organizations have used IT for managing patient
records, lab test reports, administration, etc.
• Providers have used it in developing new drugs,
manufacturing, mobility and cloud based solutions.
• Organizational structures have to evolve from industrial
era models to elastic organizational structures.
3)INDUSTRY LEVEL:
• Use of cloud technologies (Eg: Athena Health)
• Establish cross-industry collaboration, physician to
physician collaboration, patient history and education.
• Privately funded platforms to support many aspects
including insurance.
• Enabling linking of various service providers in a
common platform.
13. INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
CHALLANGES SUGGESTIONS
The expected impact of digital revolution on the healthcare industry are as follows:
DIGITAL AND IT AND INFRASTRUCTURE– EXPECTED IMPACT
1)HEALTH PLATFORMS: Technology and business care platforms that will support various functions and bring the
stakeholders together.
2)HEALTH ECOSYSTEM: The platforms will bring the various players together and enable them to get into collaborative
relationships and deliver value to the patients.
3)PERSONALIZED MEDICINE: Each individual will have their own customized plan due to Omics (Mass customization)
4)PARTICIPATIVE MEDICINE: All involved parties can be involved to take the right decision
5)PREDICTIVE MEDICINE: More emphasis will be placed on preventing the patients from falling sick
6)MASS DATA SETS: The data generated by the industry has to be analysed to make business sense
7)COGNITIVE COMPUTATION: SAP, HANA, IBM Watson
14. Omics sciences include genomics, proteomics, microbiomics, pharmacogenomics, etc.
INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
CHALLANGES SUGGESTIONS
3.RAPID ADVANCES IN OMICS SCIENCES
Advances in targeted treatments for previously thought to be incurable diseases is expected to continue
Microfluidic systems have enabled new forms of diagnostics (Theranos offers blood testing)
Detailed genetic map of each individual and their family members leading to preventive treatments
P4 Medicine: Predictive, Preventive, Participatory and Personalized care can be provided to patients
15. INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
CHALLANGES SUGGESTIONS
The expected impact of new methods on the healthcare industry are as follows:
RAPID ADVANCES IN OMICS SCIENCES – EXPECTED IMPACT
1)HIGH SPEED SEQUENCING: Each persons genomic map can be obtained rapidly
2)MICRO FLUIDICS: Ability to identify and isolate molecular level particles
3)SINGLE CELL ANALYSIS: Ability to study single cells and stem cells
4)SYSTEMS BIOLOGY: Treats the human body as composed of several sub-systems
5)REALTIME DIAGNOSTICS: Continuous monitoring of the individuals biological condition
6)PERSONALIZED MEDICINE: Each person will have a customized treatment plan
7)PREDICTIVE MEDICINE: The genome map can be used to predict diseases before they occur
8)PREVENTATIVE MEDICINE: Preventive medicine will have a lot of emphasis
16. INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
CHALLANGES SUGGESTIONS
4.RISE OF GLOBAL MIDDLE CLASS
The global middle class healthcare market will soon become larger than the US market in both dollars spent and number
of patients
Companies will have to change their business models to survive
Players in the U.S. market will eventually become global players and will have to change their strategies to face
competition
The growth of BRIC nations is rapidly increasing the size of the middle class
In 2012 the middle class ($4,000 - $20,000) consisted of 2 billion people worldwide
17. INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
CHALLANGES SUGGESTIONS
The expected impact of digital revolution on the healthcare industry are as follows:
RISE OF GLOBAL MIDDLE CLASS – EXPECTED IMPACT
1)NEW MARKETS & SCALE: The growth of middle class will create new markets on a global scale
2)EPIDEMIOLOGIES: With technology enablement the study of patterns will become common
3)MASSIVE DATA SETS: Each individual will be continuously monitored which will generate data
4)MASS DIFFERENTIATION: Each individual will have their own customized plan due to Omics
5)ELASTIC BUSINESS MODEL: Organizational structures have to evolve from industrial era models to elastic organizational
structures.
6)REVERSE INNOVATION: Innovations made in developing countries to reduce cost can be implemented in U.S.A.
7)INDUSTRY GROWTH: The increase in middle class population will lead to increase in demand for healthcare globally
18. INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
CHALLANGES ANALYSIS
Measures have to be taken to reduce the high cost of service. The limit on number of doctors has to be increased
to decrease primary care costs.
The number of people insured has to be maximised to reduce strain on emergency rooms. The PPACA envisages to
achieve this.
The administrative costs have to be brought down by usage of optimal usage of information technology packages.
The number of preventable deaths in U.S.A is 45,000. This can be avoided by decreased by offering better priced
plans.
The number of preventable deaths in U.S.A is 45,000. This can be avoided by decreased by offering better priced
plans.
19. INTRODUCTION INDUSTRY
PLAYERS
INVOLVED
CHALLANGES ANALYSIS
• Obamacare mandates for small companies to provide healthcare insurance to its employees. Large companies
were already providing this.
• Now due to PPACA, companies with 50 to 300 employees have become a new target segment.
• Technology is rapidly making customized plans available and bringing the players together. Huge amounts of
data are being generated.
• Software has to be customizable and be able to handle large sets of data.
• Genomic mapping will bring about a revolution in how people are treated.
• The software has to be customizable to accommodate frequent changes in the insurance plan structures.
• The growth of middle class has several issues. The companies for which service is provided may expand into
other countries. The IT service provider may also look to customize the offering for different countries.
• The software has to be available in different languages.